GlioCART jobs and careers
About GlioCART
GlioCART is a University of Basel spin-off focused on translating a dual-action CAR-T therapy for glioblastoma into clinical application by combining tumor targeting with immune microenvironment reprogramming. Our mission is to achieve durable clinical benefit for patients with glioblastoma.
- Employees
- 1 to 10
Leadership
The top of GlioCART's org chart, with how many people report into each leader.
DW
Dieter Willmann
Co-Founder & CEO (2025 to present)
Jobs at GlioCART
No open positions right now. Explore more companies on TheJobsMap.